Novel Single Chain Antibodies against MIF (Ibex Biosciences)

N/A

Report date: 2024/12/05 15:16:11

Base Information

Drug NameNovel Single Chain Antibodies against MIF (Ibex Biosciences)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-chain FV antibody fragment (scFv)
Mechanisms of ActionMacrophage migration inhibitory factor inhibitors
TargetsMacrophage migration inhibitory factor
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIbex Biosciences LLC
China Registration ClassN/A

Develop Information

Active CompaniesIbex Biosciences LLC
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A